Drug profile · INN
aminophylline
AMINOPHYLLINE
aminophylline (AMINOPHYLLINE) is a adenosine receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: rectal. Current US regulatory status: approved.
Drug details — aminophylline
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 20
- Programs
- 1
- Data quality
- 0.89
Quick answer
aminophylline (AMINOPHYLLINE) is a adenosine receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
Adenosine receptor antagonist
Primary target: Adenosine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
-
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12426594
Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12419866
Compounds and methods for treating an epileptic disorder
granted -
US 12421525
Conjugates comprising AAVs and CAS9 polypeptides
granted -
US 12419811
Hydrogel drug delivery composition
granted -
US 12415863
Compositions and methods for treating cancer
granted -
US 12416008
Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers
granted -
US 12414907
Peptide having hair growth promoting activity and use thereof
granted -
US 12410399
Compositions and methods for treating retinal diseases
granted -
US 12403093
Methods for production of MSC-derived exosomes
granted -
US 12403192
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 12396994
Compositions for improving physiological function with age
granted -
US 12398375
Methods for improved poxvirus yields
granted -
US 12396949
Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom
granted -
US 12391654
CFTR regulators and methods of use thereof
granted -
US 12391643
Substituted amino-thiol and amino-disulfide compounds, and uses thereof
granted -
US 12390483
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 12383534
Methods for treating cancer
granted -
US 12383518
Disulfide-masked pro-chelator compositions and methods of use
granted
Frequently asked questions
What is aminophylline?
aminophylline (AMINOPHYLLINE) is a adenosine receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for aminophylline?
AMINOPHYLLINE is a marketed brand name for aminophylline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aminophylline?
aminophylline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.